Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Heathrow denies report that third runway has been scrapped

(Sharecast News) - London's Heathrow Airport has denied a report by the Sunday Times that plans to add a third runway had been shelved. "The speculation in today's Sunday Times is wrong, and Heathrow recognises neither the plans nor actions described," said a spokesperson for the airport.

The Sunday Times claimed that Heathrow chief executive Thomas Woldbye was looking to scrap the expansion and had started to disband a team focussed on the project, citing unnamed sources.

Heathrow said it was looking at how it could best optimise the current airport to achieve short-term growth within its current infrastructure.

"Longer term, we're reviewing our plans to make sure the airport has the capacity the UK economy needs, while boosting the resilience of our operations for our customers and meeting our sustainability commitments," the statement said.

The longstanding push to build an additional runway at Heathrow has been halted by legal challenges from local residents and environmental campaigners, as well as being impacted heavily by the Covid-19 pandemic. Heathrow reported its first annual profit since 2019 just last week.

Reporting by Iain Gilbert at Shareccast.com

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.